CIK 0001665988
- Accelerated filer
- Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 810980861
- Phone
- +1 919-474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,648 shares (option exercise)
- 4 Exercise or conversion Director acquired 7,576 shares (option exercise)
- 4 Open-market buy Director bought 88,000 shares at an average $2.68 ($235,567)
- 4 Open-market buy Interim CEO bought 125,000 shares at $2.33 ($290,988)
- 4 Open-market buy Director bought 1,315,673 shares at an average $1.96 ($2,573,128)
- 4 Planned sale Fmr. Chief Commercial Officer sold 142 shares at an average $8.81 ($1,251)
- 4 Planned sale SVP & Chief Compliance Officer sold 131 shares at an average $7.69 ($1,007)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale SVP & Chief Compliance Officer sold 117 shares at $1.07 ($125)
- 4 Open-market sale SVP & CFO sold 6,044 shares at $1.27 ($7,676)
- 4 Exercise or conversion SVP & CFO acquired 18,625 shares (option exercise)
- 4 Open-market sale SVP & General Counsel sold 3,409 shares at $1.39 ($4,737)
- 4 Exercise or conversion Director acquired 3,949 shares (option exercise)
Page 8 of 13 · 251 filings